Health Care & Life Sciences » Pharmaceuticals | Cho-A Pharmaceutical Co. Ltd.

Cho-A Pharmaceutical Co. Ltd. | Balance Sheet

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Cash & Short Term Investments
10,579
9,899
9,084
7,263
14,264
Total Accounts Receivable
24,227
23,474
24,431
27,191
29,036
Inventories
6,636
7,493
7,003
6,663
9,101
Other Current Assets
1,587
1,226
1,370
2,889
675
Total Current Assets
43,029
42,093
41,889
44,005
53,076
Net Property, Plant & Equipment
15,825
20,137
20,499
21,482
19,940
Total Investments and Advances
7,270
10,663
10,095
5,875
6,767
Long-Term Note Receivable
1,146
206
650
499
496
Intangible Assets
458
386
268
481
395
Other Assets
2,624
-
-
1,869
2,715
Total Assets
71,330
74,531
75,397
76,354
86,117
ST Debt & Current Portion LT Debt
5,037
13,204
11,685
13,217
7,750
Accounts Payable
1,769
1,722
1,829
2,619
2,652
Income Tax Payable
68
367
544
538
264
Other Current Liabilities
3,976
4,036
6,807
7,706
6,096
Total Current Liabilities
10,850
19,329
20,865
24,081
16,761
Long-Term Debt
2,000
-
2,000
-
8,917
Provision for Risks & Charges
2,323
4,077
2,245
2,217
1,628
Deferred Taxes
489
572
957
897
392
Other Liabilities
5,040
4,561
2,094
1,745
3,291
Total Liabilities
20,704
28,441
28,242
29,290
32,932
Common Equity (Total)
51,184
46,716
47,858
47,839
54,176
Total Shareholders' Equity
51,184
46,716
47,858
47,839
54,176
Total Equity
50,626
46,090
47,155
47,065
53,185
Liabilities & Shareholders' Equity
71,330
74,531
75,397
76,354
86,117
Accumulated Minority Interest
558
626
703
775
991

About Cho-A Pharmaceutical Co.

View Profile
Address
#101 Ace Techno Tower
Seoul SL 07299
Korea, Republic Of
Employees -
Website http://www.choa.co.kr
Updated 09/14/2018
CHOA PHARMACEURICAL Co., Ltd. engages in the manufacture and sale of medicine and health supplement food. Its products include medicines for memory development, liver and bowels treatment, blood making nutrition, cholagogue, blood circulation, vitamins, fatigue recovery and muscle pain. The company was founded in May 1988 and is headquartered in Seoul, South Korea.